See more : LGB Forge Limited (LGBFORGE.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Baumer S.A. (BALM3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Baumer S.A., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Vinythai Public Company Limited (VYTPF) Income Statement Analysis – Financial Results
- Weiss Korea Opportunity Fund Ltd. (WKOF.L) Income Statement Analysis – Financial Results
- Newcourt Acquisition Corp (NCAC) Income Statement Analysis – Financial Results
- Benjamin Hill Mining Corp. (BNN.CN) Income Statement Analysis – Financial Results
- ChenGuang Biotech Group Co., Ltd. (300138.SZ) Income Statement Analysis – Financial Results
Baumer S.A. (BALM3.SA)
About Baumer S.A.
Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 169.95M | 329.09M | 267.64M | 325.95M | 149.31M | 119.80M | 109.75M | 113.11M | 112.04M | 116.30M | 108.70M | 99.75M | 93.51M | 94.81M | 85.20M | 74.06M | 65.30M | 65.11M | 53.94M | 45.65M | 40.28M |
| Cost of Revenue | 67.07M | 68.62M | 58.66M | 81.44M | 72.02M | 52.40M | 46.28M | 43.06M | 44.09M | 42.78M | 38.24M | 37.78M | 39.26M | 42.07M | 36.45M | 31.53M | 28.37M | 25.84M | 21.91M | 19.36M | 15.83M |
| Gross Profit | 102.88M | 260.47M | 208.98M | 244.51M | 77.29M | 67.40M | 63.47M | 70.05M | 67.96M | 73.51M | 70.46M | 61.96M | 54.25M | 52.74M | 48.75M | 42.52M | 36.94M | 39.27M | 32.02M | 26.29M | 24.46M |
| Gross Profit Ratio | 60.53% | 79.15% | 78.08% | 75.02% | 51.76% | 56.26% | 57.83% | 61.93% | 60.65% | 63.21% | 64.82% | 62.12% | 58.01% | 55.63% | 57.22% | 57.42% | 56.56% | 60.31% | 59.37% | 57.59% | 60.71% |
| Research & Development | 5.82M | 6.14M | 5.67M | 4.39M | 4.76M | 4.63M | 6.38M | 7.08M | 5.68M | 6.02M | 5.26M | 4.98M | 4.85M | 4.19M | 4.44M | 3.65M | 3.17M | 2.75M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 31.83M | 29.63M | 27.09M | 25.63M | 23.60M | 23.29M | 22.74M | 22.75M | 19.47M | 18.41M | 16.78M | 14.98M | 37.44M | 12.96M | 7.00K | 10.38M | 9.55M | 8.95M | 9.77M | 8.85M | 7.03M |
| Selling & Marketing | 41.92M | 37.34M | 29.38M | 32.37M | 36.55M | 32.93M | 30.09M | 30.59M | 26.78M | 30.59M | 27.87M | 26.51M | 0.00 | 26.83M | 36.88M | 22.51M | 20.23M | 18.44M | 16.42M | 12.92M | 13.31M |
| SG&A | 73.75M | 66.97M | 56.47M | 58.00M | 60.15M | 56.22M | 52.83M | 53.35M | 46.25M | 48.99M | 44.65M | 41.49M | 37.44M | 39.79M | 36.89M | 32.88M | 29.79M | 27.40M | 26.20M | 21.77M | 20.34M |
| Other Expenses | 0.00 | 4.93M | 779.00K | 2.09M | 3.21M | 1.16M | 936.00K | 361.00K | 1.72M | 1.27M | 1.43M | 2.45M | 2.03M | 1.47M | -926.00K | -1.28M | 509.00K | 2.38M | 605.00K | 450.00K | 1.22M |
| Operating Expenses | 79.58M | 78.04M | 62.93M | 64.48M | 68.12M | 62.01M | 60.15M | 60.78M | 53.65M | 56.28M | 51.35M | 48.92M | 44.31M | 45.46M | 42.07M | 35.25M | 33.47M | 32.52M | 26.80M | 22.22M | 21.55M |
| Cost & Expenses | 146.95M | 146.66M | 121.59M | 145.91M | 140.14M | 114.41M | 106.43M | 103.84M | 97.74M | 99.06M | 89.59M | 86.70M | 83.58M | 87.53M | 78.52M | 66.79M | 61.84M | 58.36M | 48.71M | 41.58M | 37.38M |
| Interest Income | 413.00K | 913.00K | 351.00K | 234.00K | 281.00K | 213.00K | 231.00K | 5.17M | 11.70M | 4.91M | 2.97M | 2.17M | 1.73M | 878.00K | 1.01M | 1.04M | 511.00K | 513.00K | 1.13M | 753.00K | 0.00 |
| Interest Expense | 9.56M | 1.45M | 1.64M | 970.00K | 1.18M | 1.18M | 1.22M | 8.31M | 5.86M | 4.00M | 2.46M | 1.27M | 252.00K | 1.41M | 1.59M | 2.89M | 1.12M | 1.04M | 465.00K | 1.04M | 0.00 |
| Depreciation & Amortization | 4.87M | 4.11M | 3.43M | 2.98M | 2.86M | 2.68M | 3.29M | 2.96M | 2.06M | 2.10M | 2.18M | 2.70M | 2.17M | 1.96M | -1.04M | 1.11M | 0.00 | 0.00 | 0.00 | 284.00K | 499.00K |
| EBITDA | 26.70M | 21.99M | 20.34M | 25.32M | 15.08M | 11.14M | 6.62M | 12.22M | 16.36M | 19.34M | 21.29M | 18.13M | 13.72M | 10.14M | 6.76M | 9.42M | 3.47M | 6.75M | 5.22M | 4.07M | 2.90M |
| EBITDA Ratio | 15.71% | 3.31% | 7.28% | 7.82% | 8.96% | 8.07% | 5.63% | 14.76% | 26.05% | 20.96% | 22.85% | 18.17% | 13.10% | 10.67% | 7.94% | 11.32% | 5.31% | 10.36% | 9.68% | 8.92% | 7.21% |
| Operating Income | 22.71M | 6.80M | 14.87M | 22.17M | 10.51M | 5.93M | 2.45M | 8.79M | 21.26M | 18.28M | 20.20M | 13.13M | 9.94M | 7.29M | 6.68M | 7.27M | 3.47M | 6.75M | 5.22M | 3.79M | 2.40M |
| Operating Income Ratio | 13.36% | 2.07% | 5.55% | 6.80% | 7.04% | 4.95% | 2.23% | 7.77% | 18.98% | 15.72% | 18.58% | 13.17% | 10.63% | 7.68% | 7.84% | 9.82% | 5.31% | 10.36% | 9.68% | 8.30% | 5.97% |
| Total Other Income/Expenses | -8.10M | 2.88M | 415.00K | 2.08M | -2.95M | -626.00K | 0.00 | -3.37M | 5.85M | 0.00 | 0.00 | 0.00 | -11.00K | -1.44M | -1.25M | -1.86M | -23.00K | 504.00K | 465.00K | -1.23M | 5.00K |
| Income Before Tax | 14.61M | 9.68M | 13.43M | 21.23M | 9.43M | 5.93M | 2.45M | 5.43M | 21.26M | 18.28M | 20.20M | 14.15M | 10.05M | 6.75M | 5.43M | 3.85M | 3.44M | 7.59M | 5.69M | 2.56M | 2.41M |
| Income Before Tax Ratio | 8.60% | 2.94% | 5.02% | 6.51% | 6.31% | 4.95% | 2.23% | 4.80% | 18.98% | 15.72% | 18.58% | 14.19% | 10.75% | 7.12% | 6.38% | 5.19% | 5.27% | 11.66% | 10.55% | 5.61% | 5.98% |
| Income Tax Expense | 5.67M | 3.97M | 3.30M | 4.80M | 5.23M | 3.18M | 1.99M | 2.63M | 6.25M | 5.90M | 6.07M | 5.10M | 1.88M | 3.03M | 3.45M | 1.56M | 1.83M | 2.77M | 2.31M | 1.29M | 1.54M |
| Net Income | 8.94M | 5.71M | 10.13M | 16.43M | 4.19M | 2.75M | 675.00K | 3.02M | 14.35M | 11.50M | 13.13M | 8.46M | 6.93M | 3.72M | 1.98M | 4.22M | 1.83M | 5.42M | 3.38M | 1.27M | 872.00K |
| Net Income Ratio | 5.26% | 1.73% | 3.79% | 5.04% | 2.81% | 2.30% | 0.62% | 2.67% | 12.81% | 9.89% | 12.08% | 8.48% | 7.41% | 3.92% | 2.32% | 5.69% | 2.81% | 8.33% | 6.27% | 2.79% | 2.16% |
| EPS | 0.91 | 0.59 | 1.63 | 1.74 | 0.64 | 0.28 | 0.07 | 0.31 | 1.46 | 1.17 | 1.34 | 0.86 | 0.86 | 0.71 | 0.24 | 0.24 | 0.21 | 0.62 | 0.46 | 0.21 | 0.18 |
| EPS Diluted | 0.91 | 0.59 | 1.63 | 1.74 | 0.64 | 0.28 | 0.07 | 0.31 | 1.46 | 1.17 | 1.34 | 0.86 | 0.86 | 0.71 | 0.24 | 0.24 | 0.21 | 0.62 | 0.46 | 0.21 | 0.18 |
| Weighted Avg Shares Out | 9.78M | 9.78M | 9.78M | 9.79M | 9.79M | 9.79M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 8.80M | 8.80M | 8.80M | 8.80M | 8.80M |
| Weighted Avg Shares Out (Dil) | 9.78M | 9.78M | 9.78M | 9.79M | 9.79M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 9.80M | 8.80M | 8.80M | 8.80M | 8.80M | 8.80M |
Source: https://incomestatements.info
Category: Stock Reports